adt as treatment in metastatic prostate cancer
Published 6 years ago • 1.1K plays • Length 4:43Download video MP4
Download video MP3
Similar videos
-
12:11
triggers to initiate androgen-deprivation therapy (adt) in prostate cancer
-
6:14
intermittent versus continuous androgen-deprivation therapy in prostate cancer
-
1:25
dr. mohler on overuse of adt in prostate cancer and nccn guidelines
-
3:50
considering adt’s role in advanced prostate cancer
-
4:09
intermittent versus continuous androgen deprivation therapy in prostate cancer
-
4:05
adt and its consequences in the treatment of prostate cancer
-
6:40
considerations for initiating adt in prostate cancer
-
18:55
adt-resistant metastatic prostate cancer
-
5:59
challenges associated with adt for prostate cancer
-
6:24
age, exercise, and adt for prostate cancer
-
8:17
managing bone health on adt in prostate cancer
-
2:07
dr. kantoff on docetaxel plus androgen deprivation therapy in prostate cancer
-
1:22
dr. hwang on the state of treatment in metastatic prostate cancer
-
15:49
adt resistant non-metastatic prostate cancer (nmcrpc) - 2021 prostate cancer patient conference
-
51:42
2/2/18: androgen deprivation therapy in prostate cancer: adverse effects and strategies to mitigate
-
2:53
treatment without hormone blockers helps solitary prostate cancer metastases
-
1:05
dr. shore on challenges with adt in recurrent prostate cancer
-
1:11
dr. burgess on the synergy between abiraterone and adt in prostate cancer
-
0:47
systemic triple therapy in metastatic hormone-sensitive prostate cancer